Skip to main content

Research Repository

Advanced Search

Survivin’ acute myeloid leukaemia—a personalised target for inv(16) patients (2021)
Journal Article
Dӧhner, H., Greiner, J., Brown, E., Bullinger, L., Hills, R. K., Morris, V., …Guinn, B. A. (2021). Survivin’ acute myeloid leukaemia—a personalised target for inv(16) patients. International Journal of Molecular Sciences, 22(19), https://doi.org/10.3390/ijms221910482

Abstract: Despite recent advances in therapies including immunotherapy, patients with acute myeloid leukaemia (AML) still experience relatively poor survival rates. The Inhibition of Apoptosis (IAP) family member, survivin, also known by its gene and... Read More about Survivin’ acute myeloid leukaemia—a personalised target for inv(16) patients.